Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

NCT04664179

Conditions: DNA Virus Infections, EBV Related Non-Hodgkin's Lymphoma, EBV-Related Hodgkin Lymphoma, +16 more
Locations: Harris Health System - Ben Taub General Hospital/Smith Clinic Houston, Texas, United States

Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

Baylor St. Luke's Medical Center Houston, Texas, United States

View Trial Details

Recruiting

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

NCT07453095

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: AOU SS. Antonio e Biagio e Cesare Arrigo - SCDU Ematologia Alessandria, Italy

Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli Bologna, Italy

ASST Spedali Civili - Ematologia Brescia, Italy

Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia Florence, Italy

View all 14 locations

View Trial Details

Recruiting

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

NCT06785415

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

NCT06447376

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06544785

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: H. General Univ. de Alicante Alicante, Spain

H. Clínic de Barcelona Barcelona, Spain

H. Vall d' Hebron Barcelona, Spain

Hospital del Mar Barcelona, Spain

View all 19 locations

View Trial Details

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974

Conditions: Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

NCT04573140

Conditions: Adult Glioblastoma, Astrocytoma, Brain Diseases, +25 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UF Health Gainesville, Florida, United States

View Trial Details

Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations: Emory Winship Cancer Institute Atlanta, Georgia, United States

Community Health Network Indianapolis, Indiana, United States

The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

View all 39 locations

View Trial Details

Recruiting

Ocular Manifestations of Granulomatosis With Polyangiitis.

NCT07664709

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +21 more
Locations: Military Institute of Medicine National Research Institute Warsaw, Poland

View Trial Details

Recruiting

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

NCT07468136

Conditions: Anaplastic Oligodendroglioma, Astrocytoma, Astrocytoma, IDH-Mutant, Grade 3, +22 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions